This inventor holds 1 USPTO granted patent. Top assignee: National Cancer Center. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Il-Ju Choi: Innovator in Cancer Therapeutics
Introduction
Il-Ju Choi is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer research, particularly in the development of therapeutic agents. His innovative approach focuses on the molecular interactions involved in cancer progression.
Latest Patents
Il-Ju Choi holds a patent for a method titled "Method for screening cancer therapeutic agent using galectin-3, GSK-3β, and fascin-1." This patent discloses a novel method for screening cancer therapeutic agents that exhibit down-regulation of galectin-3 and fascin-1 or interfere with the interaction between galectin-3 and GSK-3β. He has 1 patent to his name, showcasing his commitment to advancing cancer treatment.
Career Highlights
Choi is affiliated with the National Cancer Center, where he conducts research aimed at improving cancer therapies. His work is pivotal in understanding the mechanisms of cancer and developing effective treatment strategies.
Collaborations
Some of his notable coworkers include Kyung-Hee Chun and Seok-Jun Kim. Their collaborative efforts contribute to the advancement of cancer research and therapeutic development.
Conclusion
Il-Ju Choi's innovative work in cancer therapeutics exemplifies the importance of research in combating this disease. His contributions are vital for the future of cancer treatment and highlight the role of inventors in medical advancements.